Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Infect Immun
1999 Jan 01;671:80-7. doi: 10.1128/IAI.67.1.80-87.1999.
Show Gene links
Show Anatomy links
Localization of the intracellular activity domain of Pasteurella multocida toxin to the N terminus.
Wilson BA
,
Ponferrada VG
,
Vallance JE
,
Ho M
.
???displayArticle.abstract???
We have shown that Pasteurella multocida toxin (PMT) directly causes transient activation of Gqalpha protein that is coupled to phosphatidylinositol-specific phospholipase Cbeta1 in Xenopus oocytes (B. A. Wilson, X. Zhu, M. Ho, and L. Lu, J. Biol. Chem. 272:1268-1275, 1997). We found that antibodies directed against an N-terminal peptide of PMT inhibited the toxin-induced response in Xenopus oocytes, but antibodies against a C-terminal peptide did not. To test whether the intracellular activity domain of PMT is localized to the N terminus, we conducted a deletion mutational analysis of the PMT protein, using the Xenopus oocyte system as a means of screening for toxin activity. Using PCR and conventional cloning techniques, we cloned from a toxinogenic strain of P. multocida the entire toxA gene, encoding the 1,285-amino-acid PMT protein, and expressed the recombinant toxin as a His-tagged fusion protein in Escherichia coli. We subsequently generated a series of N-terminal and C-terminal deletion mutants and expressed the His-tagged PMT fragments in E. coli. These proteins were screened for cytotoxic activity on cultured Vero cells and for intracellular activity in the Xenopus oocyte system. Only the full-length protein without the His tag exhibited activity on Vero cells. The full-length PMT and N-terminal fragments containing the first 500 residues elicited responses in oocytes, but the C-terminal 780 amino acid fragment did not. Our results confirm that the intracellular activity domain of PMT is localized to the N-terminal 500 amino acids of the protein and that the C terminus is required for entry into cells.
Ackermann,
Tonsil and turbinate colonization by toxigenic and nontoxigenic strains of Pasteurella multocida in conventionally raised swine.
1994, Pubmed
Ackermann,
Tonsil and turbinate colonization by toxigenic and nontoxigenic strains of Pasteurella multocida in conventionally raised swine.
1994,
Pubmed
Barbour,
Bacterial identity and characteristics in healthy and unhealthy respiratory tracts of sheep and calves.
1997,
Pubmed
Biberstein,
Our understanding of the Pasteurellaceae.
1990,
Pubmed
Biberstein,
Distribution of indole-producing urease-negative pasteurellas in animals.
1991,
Pubmed
Bisgaard,
Ecology and significance of Pasteurellaceae in animals.
1993,
Pubmed
Buys,
Sequence of the dermonecrotic toxin of Pasteurella multocida ssp. multocida.
1990,
Pubmed
Chrisp,
Induction of pneumonia in rabbits by use of a purified protein toxin from Pasteurella multocida.
1991,
Pubmed
Dudet,
Pasteurella multocida toxin stimulates mitogenesis and cytoskeleton reorganization in Swiss 3T3 fibroblasts.
1996,
Pubmed
Falbo,
Isolation and nucleotide sequence of the gene encoding cytotoxic necrotizing factor 1 of Escherichia coli.
1993,
Pubmed
Flatau,
Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine.
1997,
Pubmed
Foged,
Quantitation and purification of the Pasteurella multocida toxin by using monoclonal antibodies.
1988,
Pubmed
Foged,
Pasteurella multocida toxin. The characterisation of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs.
1992,
Pubmed
Frymus,
Toxigenic Pasteurella multocida in rabbits with naturally occurring atrophic rhinitis.
1991,
Pubmed
Garcia,
Animal bites and Pasturella infections.
1997,
Pubmed
Griego,
Dog, cat, and human bites: a review.
1995,
Pubmed
Gwaltney,
Effects of Pasteurella multocida toxin on porcine bone marrow cell differentiation into osteoclasts and osteoblasts.
1997,
Pubmed
Higgins,
Pasteurella multocida toxin is a potent inducer of anchorage-independent cell growth.
1992,
Pubmed
Horiguchi,
Bordetella bronchiseptica dermonecrotizing toxin induces reorganization of actin stress fibers through deamidation of Gln-63 of the GTP-binding protein Rho.
1997,
Pubmed
Hubbert,
Pasteurella multocida Infections: I. Pasteurella Multocida Infection Due to Animal Bite.
1970,
Pubmed
Jutras,
Stimulation of osteoclast-like cell formation by Pasteurella multocida toxin from hemopoietic progenitor cells in mouse bone marrow cultures.
1996,
Pubmed
Kamps,
Cloning and expression of the dermonecrotic toxin gene of Pasteurella multocida ssp. multocida in Escherichia coli.
1990,
Pubmed
Klein,
Pasteurella multocida pneumonia.
1997,
Pubmed
Lacerda,
Cytotoxic necrotizing factor 1 from Escherichia coli and dermonecrotic toxin from Bordetella bronchiseptica induce p21(rho)-dependent tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 cells.
1997,
Pubmed
Lacerda,
Pasteurella multocida toxin, a potent intracellularly acting mitogen, induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells.
1996,
Pubmed
Lax,
Cloning of the toxin gene from Pasteurella multocida and its role in atrophic rhinitis.
1990,
Pubmed
Lemichez,
Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains.
1997,
Pubmed
Morris,
Bacteremia due to Pasteurella multocida.
1992,
Pubmed
Mullan,
Pasteurella multocida toxin is a mitogen for bone cells in primary culture.
1996,
Pubmed
Murphy,
Pasteurella multocida toxin selectively facilitates phosphatidylinositol 4,5-bisphosphate hydrolysis by bombesin, vasopressin, and endothelin. Requirement for a functional G protein.
1992,
Pubmed
Oswald,
Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers.
1994,
Pubmed
Petersen,
The complete nucleotide sequence of the Pasteurella multocida toxin gene and evidence for a transcriptional repressor, TxaR.
1990,
Pubmed
Petersen,
Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis.
1991,
Pubmed
Pettit,
Receptor-mediated binding of Pasteurella multocida dermonecrotic toxin to canine osteosarcoma and monkey kidney (vero) cells.
1993,
Pubmed
Raffi,
Pasteurella multocida bacteremia: report of thirteen cases over twelve years and review of the literature.
1987,
Pubmed
Rozengurt,
Pasteurella multocida toxin: potent mitogen for cultured fibroblasts.
1990,
Pubmed
Schmidt,
Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1.
1997,
Pubmed
Staddon,
Pasteurella multocida toxin, a potent mitogen, stimulates protein kinase C-dependent and -independent protein phosphorylation in Swiss 3T3 cells.
1990,
Pubmed
Staddon,
Interconversion of GRP78/BiP. A novel event in the action of Pasteurella multocida toxin, bombesin, and platelet-derived growth factor.
1992,
Pubmed
Staddon,
Pasteurella multocida toxin, a potent mitogen, increases inositol 1,4,5-trisphosphate and mobilizes Ca2+ in Swiss 3T3 cells.
1991,
Pubmed
Waldor,
In utero infection due to Pasteurella multocida in the first trimester of pregnancy: case report and review.
1992,
Pubmed
Walker,
Characterization of the dermonecrotic toxin in members of the genus Bordetella.
1994,
Pubmed
Wilson,
Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1.
1997,
Pubmed
,
Xenbase
